Cassava: MRI Data Suggest Simufilam is Not Associated with Amyloid-related Imaging Abnormalities

 

• Safety Finding Based on Blinded MRI Brain Data at Week 40
• ARIA is a Known Risk Factor for Anti-Amyloid Antibody Drugs
• MRI Data Presented at the 16th CTAD Conference in Boston, MA

https://www.globenewswire.com/news-release/2023/10/25/2766625/8339/en/MRI-Data-Suggest-Simufilam-is-Not-Associated-with-Amyloid-related-Imaging-Abnormalities-ARIA.html